Sarah R. Klein
- Oncology top 5%
- Immunology top 5%
- Molecular Biology
- Genetics top 5%
- Epidemiology
- Co-authors
- Gordon J. FreemanArlene H. SharpeFrank A. SchildbergV. Ashutosh RaoEmily ShacterCandelaria Gomez‐ManzanoHong JiangJuàn Fueyo
- Topics
- Immunotherapy and Immune Responses (6 papers)Cancer Immunotherapy and Biomarkers (5 papers)Immune cells in cancer (5 papers)
- Cited by
- OncologyImmunologyGenetics
- Journals
- Journal of Biological ChemistrySHILAP Revista de lepidopterologíaImmunity
- Partner nations
- United StatesSpainCanada
In The Last Decade
Sarah R. Klein
20 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Oncology 674
- Immunology 506
- Molecular Biology 406
- Genetics 235
- Epidemiology 164
Countries citing papers authored by Sarah R. Klein
This map shows the geographic impact of Sarah R. Klein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah R. Klein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah R. Klein more than expected).
Fields of papers citing papers by Sarah R. Klein
This network shows the impact of papers produced by Sarah R. Klein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah R. Klein. The network helps show where Sarah R. Klein may publish in the future.
Co-authorship network of co-authors of Sarah R. Klein
This figure shows the co-authorship network connecting the top 25 collaborators of Sarah R. Klein. A scholar is included among the top collaborators of Sarah R. Klein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah R. Klein. Sarah R. Klein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 11 | |
| 3 | 2 | |
| 4 | 4 | |
| 5 | 5 | |
| 6 | 0 | |
| 7 | Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Familybreakdown → | 437 |
| 8 | 19 | |
| 9 | 302 | |
| 10 | 41 | |
| 11 | 1 | |
| 12 | 2 | |
| 13 | 21 | |
| 14 | 46 | |
| 15 | Autophagy regulation in cancer development and therapy. | 63 |
| 16 | 124 | |
| 17 | 139 | |
| 18 | 115 | |
| 19 | [Immunoregulation of tumor growth in a murine model]. | 1 |
| 20 | Reduced cardiotoxicity and nephrotoxicity with preservation of antitumor activity of doxorubicin entrapped in stable liposomes in the LOU/M Wsl rat. | 104 |
About Sarah R. Klein
Sarah R. Klein is a scholar working on Biological Psychiatry, Immunology and Oncology, having authored 21 papers that have together received 1.4k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Immune cells in cancer (5 papers). The work is most often cited by research in Oncology (674 citations), Immunology (506 citations) and Genetics (235 citations). Sarah R. Klein has collaborated with scholars based in United States, Spain and Canada. Frequent co-authors include Gordon J. Freeman, Arlene H. Sharpe, Frank A. Schildberg, V. Ashutosh Rao, Emily Shacter, Candelaria Gomez‐Manzano, Hong Jiang, Juàn Fueyo, Eriko Toyoda and Noritaka Adachi. Their work appears in journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.